Hisham Hussan1,2, Alyssa Drosdak3, Melissa Le Roux4, Kishan Patel5, Kyle Porter6, Steven K Clinton7,8, Brian Focht9, Sabrena Noria10. 1. Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH, USA. hisham.hussan@osumc.edu. 2. The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. hisham.hussan@osumc.edu. 3. Department of Internal Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA. 4. Ohio State University College of Medicine, Columbus, OH, USA. 5. Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH, USA. 6. Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA. 7. The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. 8. Division of Medical Oncology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH, USA. 9. Department of Human Sciences, Ohio State University, Columbus, OH, USA. 10. Division of General and Gastrointestinal Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Abstract
BACKGROUND: Evolving epidemiological data, backed by mechanistic evidence, supports a paradoxical increase in the risk of colorectal cancer after Roux-en-Y gastric bypass surgery (RYGB). We examined the risk of colonic polyps after RYGB. METHODS: A single-center retrospective study included colonoscopies performed between the years 1994 and 2018. To focus on the long-term impact of RYGB on precancerous colonic polyps, we compared patients at average risk for CRC who underwent colonoscopy ≥ 5 years after RYGB (n = 86) versus pre-RYGB (n = 106). We analyzed our data using inverse probability of treatment weighting (IPTW) using propensity scores in order to account for multiple potential confounders. RESULTS: After IPTW, we found no statistical differences between pre- and post-RYGB patients for risk of any polyp (33.2% pre- vs. 32.7% post-RYGB). However, the percentage of serrated polyps was higher ≥ 5 years post-RYGB compared with pre-RYGB (8.7% vs. 2.1%, p = 0.04, relative risk = 4.22; 95% CI 0.97, 18.4). Body mass index ≥ 30 kg/m2 at time of colonoscopy was associated with a greater risk for any polyp after RYGB (OR 6.23; 95% CI 1.16, 33.41). There was also a trend towards increased risk of polyps in post-RYGB patients who were current smokers (OR = 4.97; 95% CI 0.82, 30) or with age > 55 years (OR = 2.49; 95% CI 0.88, 7.00). CONCLUSION: Our data suggest that RYGB is associated with an increased risk of serrated polyps after 5 years from surgery. Prospective studies defining this risk and examining mechanisms will be instrumental for application of CRC preventative strategies in this population.
BACKGROUND: Evolving epidemiological data, backed by mechanistic evidence, supports a paradoxical increase in the risk of colorectal cancer after Roux-en-Y gastric bypass surgery (RYGB). We examined the risk of colonic polyps after RYGB. METHODS: A single-center retrospective study included colonoscopies performed between the years 1994 and 2018. To focus on the long-term impact of RYGB on precancerous colonic polyps, we compared patients at average risk for CRC who underwent colonoscopy ≥ 5 years after RYGB (n = 86) versus pre-RYGB (n = 106). We analyzed our data using inverse probability of treatment weighting (IPTW) using propensity scores in order to account for multiple potential confounders. RESULTS: After IPTW, we found no statistical differences between pre- and post-RYGB patients for risk of any polyp (33.2% pre- vs. 32.7% post-RYGB). However, the percentage of serrated polyps was higher ≥ 5 years post-RYGB compared with pre-RYGB (8.7% vs. 2.1%, p = 0.04, relative risk = 4.22; 95% CI 0.97, 18.4). Body mass index ≥ 30 kg/m2 at time of colonoscopy was associated with a greater risk for any polyp after RYGB (OR 6.23; 95% CI 1.16, 33.41). There was also a trend towards increased risk of polyps in post-RYGB patients who were current smokers (OR = 4.97; 95% CI 0.82, 30) or with age > 55 years (OR = 2.49; 95% CI 0.88, 7.00). CONCLUSION: Our data suggest that RYGB is associated with an increased risk of serrated polyps after 5 years from surgery. Prospective studies defining this risk and examining mechanisms will be instrumental for application of CRC preventative strategies in this population.
Authors: David A Lieberman; J Lucas Williams; Jennifer L Holub; Cynthia D Morris; Judith R Logan; Glenn M Eisen; Patricia Carney Journal: Gastroenterology Date: 2014-04-29 Impact factor: 22.682
Authors: Daniel P Schauer; Heather Spencer Feigelson; Corinna Koebnick; Bette Caan; Sheila Weinmann; Anthony C Leonard; J David Powers; Panduranga R Yenumula; David E Arterburn Journal: Ann Surg Date: 2019-01 Impact factor: 12.969
Authors: Elizabeth D Kantor; Ruzan Udumyan; Lisa B Signorello; Edward L Giovannucci; Scott Montgomery; Katja Fall Journal: Gut Date: 2015-05-18 Impact factor: 23.059
Authors: Rafael M Laurino Neto; Fernando A M Herbella; Renato M Tauil; Fabricio S Silva; Sizenando E de Lima Journal: Obes Surg Date: 2012-10 Impact factor: 4.129
Authors: Prashant Kant; Anita Sainsbury; Karen R Reed; Stephen G Pollard; Nigel Scott; Alan R Clarke; P Louise Coletta; Mark A Hull Journal: Gut Date: 2011-02-08 Impact factor: 23.059